{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0776c8-2026-09-21T16:12:27+01:00",
    "date": "2026-09-21T16:12:27+01:00",
    "ocid": "ocds-h6vhtk-0776c8",
    "description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 01/10/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/><br/>Written representations should be sent to chris.grove@nhs.net<br/><br/>Decision-makers:<br/><br/>John Burchill - Programme Lead (Cancer Prevention and Screening)<br/>Elizabeth Pegers - Programme Director<br/>Nicola Sinnett - Procurement Head of Category (Diagnostics & Pathology)<br/>Keith Hinchliffe - Procurement Director (Healthcare Solutions)<br/>Troy Hinds - Senior Strategic Finance Lead<br/>Adedoyin Ogunbiyi - Chief Financial Officer<br/><br/>There were no identified conflicts of interest of individuals making the decision.<br/><br/>The five key criteria used by the authority in making its decision were:<br/><br/>Key criteria 1: Quality and innovation - 30% weighting<br/>i) That the provider can ensure a safe and quality end to end service from participant identification through to clinical decision making and downstream referral through the lung cancer screening programme. <br/>ii) That the provider can continue to develop and implement new or significantly improved services or processes to continue to improve the delivery and efficiency for the lung cancer screening programme continuing to identify lung cancers at an early stage in comparison to the symptomatic pathway.<br/><br/>Key criteria 2: Value: - 20% weighting<br/>That the provider demonstrates on going value. That the quality of the service, overall patient experience and downstream requirements are met balancing the overall costs, system and patient benefits and the financial implication of a proposed contracting arrangement.<br/><br/>Key criteria 3: Integration, collaboration and service sustainability - 20% weighting<br/>That the provider can deliver an integrated, collaborative and sustainable service in the following ways:<br/>(i) an integrated service (including with other health care services, health-related services or social care services),<br/>(ii) a collaborative service (including with providers and with persons providing health-related services or social care services), and<br/>(iii) a sustainable service (which includes the stability of good quality health care services or service continuity of health care services),so as to improve health outcomes,<br/><br/>Key criteria 4. Improving access, reducing health inequalities and facilitating choice - 20% weighting<br/>That the provider is improving access, reducing health inequalities and facilitating choice throughout the lung cancer screening pathway. That the provider is ensuring accessibility to services and treatments for all eligible patients, improving health inequalities and ensuring that patients have choice in respect of their health care.<br/><br/>Key criteria 5: Social value - 10% weighting<br/>That the provider can demonstrate social value, to improve economic, social and environmental well-being in the geographical area relevant to a proposed contracting arrangement.<br/><br/>InHealth demonstrates a strong ability to meet all five key PSR criteria in delivering the Lung Cancer Screening Programme across North West and South West London. The provider delivers high-quality, outcome-focused services with a clear emphasis on early diagnosis and continuous innovation. Its scalable and efficient delivery model provides value for money while integrating effectively across system partners. InHealth's community-based approach materially improves access and reduces inequalities in high-risk populations, while also delivering wider social value through local engagement and population health benefits. Taken together, this provides confidence in the provider's capability to deliver a sustainable, high-performing screening service across the whole geography.",
    "initiationType": "tender",
    "tender": {
        "id": "C472731",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "The provision of West London Targeted Lung Health Check Programme",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "85150000",
            "description": "Medical imaging services"
        },
        "mainProcurementCategory": "services",
        "description": "West London Targeted Lung Health Check Programme: Royal Marsden Hospital on behalf of RM Partners Cancer Alliance",
        "lots": [
            {
                "id": "1",
                "description": "The Lung Cancer Screening Programme delivers targeted lung health checks to people at increased risk of lung cancer (aged 55-74 with a history of smoking) with the aim of detecting the disease earlier, improving outcomes and reducing health inequalities. The service includes identification and invitation of eligible individuals, lung health assessments leading to referral for low-dose CT scanning where indicated, appropriate onward referral, and access to smoking cessation support. The programme is delivered collaboratively across primary care, diagnostic and secondary care settings and is governed by national quality and assurance requirements.<br/><br/>The Royal Marsden NHS Foundation Trust are intending to award a contract to an existing provider following a direct award process C under The Health Care Services (Provider Selection Regime) Regulations 2023.<br/><br/>The lifetime value of the contract (2.5 years with an optional 1 year extension possible) is PS28,452,105.<br/><br/>Contract start date: 05/10/2026<br/>Initial contract end date: 04/04/2029<br/>Maximum end date (including optional extension): 04/04/2030",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKI"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_OUTSIDE_SCOPE",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 01/10/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR."
    },
    "awards": [
        {
            "id": "089313-2026-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-181707",
                    "name": "Inhealth Limited"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-170128",
            "name": "The Royal Marsden NHS Foundation Trust",
            "identifier": {
                "legalName": "The Royal Marsden NHS Foundation Trust"
            },
            "address": {
                "streetAddress": "Fulham Road",
                "locality": "London",
                "region": "UKI33",
                "postalCode": "SW3 6JJ",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Chris Grove",
                "email": "chris.grove@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.royalmarsden.nhs.uk",
                "buyerProfile": "https://www.royalmarsden.nhs.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-181707",
            "name": "Inhealth Limited",
            "identifier": {
                "legalName": "Inhealth Limited",
                "id": "05190234"
            },
            "address": {
                "streetAddress": "Burnham Yard, London End, Beaconsfield",
                "locality": "Buckingham",
                "region": "UKJ13",
                "postalCode": "HP9 2JH",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "telephone": "+44 1494560000"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "url": "http://www.inhealthgroup.com",
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-130973",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "Wellington House, 133-135 Waterloo Rd",
                "locality": "London",
                "postalCode": "SE1 8UG",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "england.commercialqueries@nhs.net"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.england.nhs.uk/"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-170128",
        "name": "The Royal Marsden NHS Foundation Trust"
    },
    "contracts": [
        {
            "id": "089313-2026-1",
            "awardID": "089313-2026-1",
            "status": "active",
            "value": {
                "amount": 28452105,
                "currency": "GBP"
            },
            "dateSigned": "2026-09-21T00:00:00+01:00"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            }
        ]
    },
    "language": "en"
}